Last $119.75 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 4:30 PM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).

sartorius ag-vorzug (SUVPF) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/30/14 - $119.75
52 Week Low
07/30/14 - $119.75
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SARTORIUS AG-VORZUG (SUVPF)

Related News

No related news articles were found.

sartorius ag-vorzug (SUVPF) Related Businessweek News

No Related Businessweek News Found

sartorius ag-vorzug (SUVPF) Details

Sartorius Aktiengesellschaft provides laboratory and process technologies and equipment primarily in Europe, North America, and the Asia Pacific. It operates in three segments: Bioprocess Solutions, Lab Products & Services, and Industrial Weighing. The Bioprocess Solutions segment offers single-use filter membranes, single-use and reusable bioreactors, single-use bags, tubing, connectors, containers, and cell culture media, as well as filtration systems, filter integrity testing equipment, and sophisticated services for manufacturing active pharmaceutical ingredients in upstream and downstream applications. The Lab Products & Services segment primarily manufactures and markets a range of consumables, such as laboratory filters and pipette tips, as well as premium laboratory instruments, including laboratory balances, pipettes, and laboratory water purification systems. This segment serves research and quality assurance laboratories of the pharmaceutical, chemical, and food industries. The Industrial Weighing segment offers weighing and control equipment comprising process analytical and inspection systems, such as load cells for high load applications, checkweighers, metal detectors, and industrial scales. It serves food, chemical, and pharmaceutical industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Goettingen, Germany.

6,237 Employees
Last Reported Date: 07/23/14
Founded in 1870

sartorius ag-vorzug (SUVPF) Top Compensated Officers

Chairman of Executive Board and Group Chief E...
Total Annual Compensation: €922.0K
Member of The Executive Board and Executive V...
Total Annual Compensation: €568.0K
Executive for Labor Relations and Member of T...
Total Annual Compensation: €404.0K
Compensation as of Fiscal Year 2013.

sartorius ag-vorzug (SUVPF) Key Developments

Sartorius Aktiengesellschaft Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-09-2014

Sartorius Aktiengesellschaft Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-09-2014 . Venue: The Grand Hyatt Hotel, New York, New York, United States.

Sartorius Group Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Sartorius Group reported earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported net profit attributable to shareholders of the company of EUR 11.4 million, or EUR 0.67 per ordinary share, compared to EUR 14.3 million, or EUR 0.84 per ordinary share, for the same quarter ended June 30, 2013. Sales revenue was EUR 243.1 million, compared to EUR 226.9 million for the same quarter ended June 30, 2013. For the six months, the company reported net profit attributable to shareholders of the company of EUR 22.4 million, or EUR 1.31 per ordinary share, compared to EUR 27.1 million, or EUR 1.58 per ordinary share, for the same period ended June 30, 2013.

Sartorius Announces Consolidated Earnings Results for the First Six Months of Fiscal 2014; Confirms the Earnings Guidance for the Full Year of Fiscal 2014

Sartorius announced consolidated earnings results for the first six months of fiscal 2014. For the six months, the company announced that sales revenue also grew significantly at 7.8% (reported increase of 5.7%), attaining EUR 466.3 million compared with EUR 441.3 million in the year-earlier period. The group increased its underlying EBITDA by 4.8% to EUR 88.8 million. Group EBIT, including extraordinary items, depreciation and amortization, amounted to EUR 59.6 million. Relevant net profit for the group totaled EUR 31.3 million compared to EUR 32.3 million for the same period a year ago. Its respective earnings per ordinary share were EUR 1.82 (compared to EUR 1.88 for the same period a year ago), and per preference share EUR 1.84 (compared to EUR 1.90 for the same period a year ago). The company confirmed the earnings guidance for the full year of fiscal 2014. The company continues to project that in constant currencies, sales will grow from 8% to 10% and the underlying EBITDA margin will increase year over year from 19.5% to around 20.0% for the full year.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SUVPF:US $119.75 USD 0.00

SUVPF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CLARCOR Inc $63.91 USD +0.07
Donaldson Co Inc $40.76 USD -0.21
ESCO Technologies Inc $34.85 USD -0.28
Mettler-Toledo International Inc $256.43 USD -0.93
Pall Corp $83.63 USD +0.05
View Industry Companies

Industry Analysis


Industry Average

Valuation SUVPF Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 17.5x
TEV/Sales 0.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SARTORIUS AG-VORZUG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at